Abstract
Autoimmune pancreatitis (AIP) is the pancreatic manifestation of the multiorgan syndrome currently referred to as IgG4-related disease (IgG4-RD). Although AIP and the other organ manifestations of IgG4-RD characteristically respond to steroid treatment, a subset of individuals has disease that is difficult to control, including those who are unable to tolerate high-dose steroids, develop steroid dependence, or have frequent relapses despite maintenance treatment. Existing data suggest that immunomodulatory agents and rituximab (RTX) may be helpful for some to achieve and maintain remission; however, additional studies demonstrating efficacy are needed.
Original language | English (US) |
---|---|
Title of host publication | Autoimmune Pancreatitis |
Publisher | Springer Berlin Heidelberg |
Pages | 155-160 |
Number of pages | 6 |
ISBN (Electronic) | 9783642550867 |
ISBN (Print) | 9783642550850 |
DOIs | |
State | Published - Jan 1 2015 |
ASJC Scopus subject areas
- General Medicine